this characteristic was found to be present after administration of sulphinpyrazone , clofibrate , ticlopidine , suloctidil , dipyridamole ( in patients with artificial heart valves ) and dipyridamole ( in patients with venous thrombosis ) .
C0040207
ticlopidine
C0042487
venous thrombosis